Clinical Trials Directory

Trials / Completed

CompletedNCT05195047

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination: A Prospective, Randomized, Double-blind, Placebo-Controlled Trial (Trial 2)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

Preliminarily explore the effect of oral probiotics in SARS-CoV-2 serum neutralizing antibody titer level and T cell response level (spot formation cell counting). Provide a reference for determining the appropriate oral regimen. Provide necessary parameters for estimating the sample size of confirmatory clinical trial.

Detailed description

In selected communities or assigned clinical trial institutions, participants who intend to complete the third dose of SARS-CoV-2 vaccination will be invited in this study. Informed consent form will give to potential participants with well explained of trial contents during baseline. Participants who gave their signed informed consent form will be blocked randomized in a 1:1:1:1 ratio to intervention group A, intervention group B, intervention group C, or placebo group D.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT1 week placebo(Week 1)1 week of consecutively consuming oral placebo (1 time/day)
DIETARY_SUPPLEMENT1 week of probiotics(Week 1)1 week of consecutively consuming oral probiotics (1 time/day)
DIETARY_SUPPLEMENT1 week placebo(Week 2)1 week of consecutively consuming oral placebo (1 time/day)
DIETARY_SUPPLEMENT1 week of probiotics(Week 2)1 week of consecutively consuming oral probiotics (1 time/day)
DIETARY_SUPPLEMENT1 week placebo(Week 3)1 week of consecutively consuming oral placebo (1 time/day)
DIETARY_SUPPLEMENT1 week of probiotics(Week 3)1 week of consecutively consuming oral probiotics (1 time/day)

Timeline

Start date
2022-02-27
Primary completion
2022-08-21
Completion
2022-08-21
First posted
2022-01-18
Last updated
2022-11-03

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05195047. Inclusion in this directory is not an endorsement.